Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on California Business Digest.
Press releases published on May 27, 2025

Gabelli Funds to Host 17th Annual Media & Entertainment Symposium Thursday, June 5, 2025
GREENWICH, Conn., May 27, 2025 (GLOBE NEWSWIRE) -- Gabelli Funds will host its 17th Annual Media …

NeurAxis to Participate in the Lytham Partners Spring 2025 Investor Conference on May 29, 2025
CARMEL, Ind., May 27, 2025 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies addressing chronic and debilitating conditions in children and adults …

NewAmsterdam Pharma to Participate at Upcoming Investor Conferences in June
NAARDEN, the Netherlands and MIAMI, May 27, 2025 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for patients at …

authID Announces its 2025 Board of Directors Nominees Ahead of Annual Meeting
Highly Qualified New Board Nominees Will Strengthen authID’s mission to Drive Growth and Value Creation for Shareholders 2025 Annual Meeting to be Held on June 26, 2025 DENVER, May 27, 2025 (GLOBE NEWSWIRE) -- authID® (Nasdaq: AUID)(“authID” or the “ …

Veterans-Turned-Tradesmen Use Their Craftsmen Skills and Tools at Hand To Fight Crime and Terrorism On American Soil In Newly Published Action Thriller
Charleston, SC, May 27, 2025 (GLOBE NEWSWIRE) -- Based on recent studies and statistics, veterans are more likely than non-veterans to work in blue-collar jobs like installation, maintenance, and repair, as well as transportation and material moving. …

Immutep’s Efti with Radiotherapy & KEYTRUDA® (pembrolizumab) Meets Primary Endpoint in Phase II for Soft Tissue Sarcoma
Novel combination with efti has met the trial’s primary endpoint of tumour hyalinization/fibrosis in the neoadjuvant setting for patients with resectable soft tissue sarcoma Detailed results are planned for presentation at a future medical meeting SYDNEY, …

Multi Ways Holdings Reports Financial Results for Fiscal Year 2024
SINGAPORE, May 27, 2025 (GLOBE NEWSWIRE) -- Multi Ways Holdings Limited (“Multi Ways”, the “Company” or the “Issuer”) (NYSE American: MWG), a leading supplier of a wide range of heavy construction equipment for sales and rental in Singapore and the …

Reflect Scientific, Inc. Announces Strategic Cost-Cutting Initiative to Reduce SG&A Expenses by Up to 35% in 2025
OREM, Utah, May 27, 2025 (GLOBE NEWSWIRE) -- Reflect Scientific, Inc. (Symbol: RSCF), a leading innovator in cryogenic cooling technologies, today announced a comprehensive initiative to reduce Selling, General …

Days Inns - Canada Strengthens Three-Year Partnership with Food Banks Canada Through “After the Bell” Program
Toronto, ON, May 27, 2025 (GLOBE NEWSWIRE) -- Days Inns - Canada proudly extends its meaningful partnership with Food Banks Canada for a third consecutive year, supporting the After the Bell program with a significant donation aimed at tackling childhood …

Murray Brook Minerals, Puma’s Subsidiary, Closes $220,000 Private Placement
RIMOUSKI, Quebec, May 27, 2025 (GLOBE NEWSWIRE) -- Puma Exploration Inc. (TSXV: PUMA) (“Puma”), announces that its subsidiary, Murray Brook Minerals Inc. (“MBM” or “Murray Brooks Minerals”) has closed a non-brokered offering consisting of 4,400,000 flow- …

NeuroPace Announces Preliminary Results from One-Year Data in NAUTILUS Study
-- NeuroPace has completed the primary endpoint analysis of the one-year data from the first and only clinical study to evaluate neuromodulation therapy for idiopathic generalized epilepsy -- Study met the 12-week post-implant primary safety endpoint, …

ORYZON to Provide Corporate Progress Updates at Several Events in May-June
Foro MedCap 2025 BIO International Convention 2025 Discovery and Development Europe 2025 MADRID and CAMBRIDGE, Mass., May 27, 2025 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company and a …

Zscaler to Host Innovations Briefing for Investors at Zenith Live 2025
SAN JOSE, Calif., May 27, 2025 (GLOBE NEWSWIRE) -- Zscaler, Inc. (NASDAQ: ZS), the leader in cloud security, today announced that the company will host an innovations briefing for investors on June 3, 2025. The briefing will take place in Las Vegas, Nevada …

BC Real Estate Association Calls for New Short-Term Rental Exemptions Amidst Tariff Challenges and Expected High Tourism Demand
Vancouver, May 27, 2025 (GLOBE NEWSWIRE) -- In BC’s current tariff- and trade-challenged environment, provincial priorities need to adapt. While affordable housing is a critical provincial issue, so are provincial economic wellbeing and the health of our …

ORIC® Pharmaceuticals to Present Initial Data from Phase 1b Trial of ORIC-944 in Combination with Androgen Receptor Inhibitors in Patients with mCRPC
SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, May 27, 2025 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced …

Lightbridge Outlines Opportunities Created by President Trump's Nuclear Executive Orders
RESTON, Va, May 27, 2025 (GLOBE NEWSWIRE) -- Lightbridge Corporation (“Lightbridge” or the “Company”) (Nasdaq: LTBR), an advanced nuclear fuel technology company, today announced how President Trump's recent nuclear energy Executive Orders (the “Executive …

Domestic Metals Announces Non-Brokered Private Placement and Change of CFO and Corporate Secretary
**NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES** VANCOUVER, British Columbia, May 27, 2025 (GLOBE NEWSWIRE) -- Domestic Metals Corp. (the “Company” or “Domestic”) - (TSXV: DMCU; OTCQB: DMCUF; FSE: 03E) …

Palvella Therapeutics Strengthens Executive Leadership Team with Appointment of Rare Disease Commercial Veteran Ashley Kline as Chief Commercial Officer
Ms. Kline to lead Palvella’s commercial buildout for planned standalone U.S. launch of QTORIN™ 3.9% rapamycin anhydrous gel (QTORIN™ rapamycin) for microcystic lymphatic malformations, a serious, rare, and lifelong genetic disease affecting an estimated …

LENZ Therapeutics to Present at Upcoming Investor Conferences
SAN DIEGO, May 27, 2025 (GLOBE NEWSWIRE) -- LENZ Therapeutics, Inc. (Nasdaq: LENZ or “LENZ” or the “Company”), a pre-commercial stage biopharmaceutical company focused on the development and commercialization of the first and only aceclidine-based eye drop …

CanadianSME Small Business Show 2025: Thriving in the Digital-First Economy
MISSISSAUGA, Ontario, May 27, 2025 (GLOBE NEWSWIRE) -- The highly anticipated CanadianSME Small Business Show 2025 is set to return to the Metro Toronto Convention Centre – North Building, Level 100 on May 29, 2025, bringing together small business owners, …